Searched for
BIOTECHNOLOGY LED ENTERPRISES
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- BRICS+ agriculture beyond borders: Trade and resilience for a food-secure worldWith India’s leadership and BRICS+ cooperation, agriculture can become not only a source of food, but a foundation for resilience, prosperi...
- India, Germany explore cooperation in quantum communication, space and deep-tech innovationIndia and Germany on Tuesday explored expanded cooperation in quantum communication, photonics, quantum satellite communication, space tech...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Karnataka launches India’s first state-led spacetech CoE in BengaluruKarnataka has launched India's first state-led Centre of Excellence for Space Technology (CoE SpaceTech Foundation) in Bengaluru. This init...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Karnataka's bioeconomy reaches $39 billion in 2025: ReportThe Karnataka Bioeconomy Report 2025, released by the state's IT/BT ministry, in collaboration with the Association of Biotechnology Led En...
- South leads in bioeconomy boom with 45.4% share in 2024In 2024, South India led India's bioeconomy, contributing 45.4% ($75.2 billion), with Maharashtra, Karnataka, and Telangana emerging as key...
- Kiran Mazumdar Shaw elected first non-executive chairman of ABLEP M Murali, Managing Director and CEO, Evolva Biotech, was re-elected as President for a second term at the meet here last week, an ABLE re...
- 'Indian biotech industry is on the cusp of entering a new era'It needs only to address some fundamental areas of policy and regulation, and take steps towards creating an environment that encourages, n...
- Decision on GM crops must be based on data, says ABLE-AGAfter India allowed planting of Bt Cotton in 2002, it transformed from being an importer of cotton in 2002, to the second largest exporter ...
- Keep clinical trial services out of service tax ambit: Association of Biotechnology Led EnterprisesAs per the Union budget 2014, these services, which were previously exempt, would now attract service tax of 12.36 per cent.
- India needs Rs 30,000 crore investment per annum for biotech sector: ExpertsTo provide affordable healthcare with innovative medicines, India needs an investment of Rs 30,000 cr annually in next 5 years, say industr...
- Healthy debate required on biotechnology: Tariq AnwarConsidering biotechnology to be area of focus in improving farm productivity, Union Minister of State for Agriculture Tariq Anwar said ther...
- Deal to exchange technical knowledge, info on biotech inkedABLE and BIRAC have signed an agreement to facilitate technical knowledge and exchange information on the biotech industry.
- Budget 2013: Proposals not encouraging for biotech sector, says expertPM Murali, President, Association of Biotechnology Led Enterprises (ABLE) says the Union Budget for 2013-14 is not encouraging for the biot...
- Remove moratorium on Bt Brinjal: Biotech bodyIndustry body for agri-biotech sector ABLE today asked the government to remove the moratorium on commercial cultivation of Bt brinjal.
- ABLE, WBBA ink MoU to support 'breakthrough' discoveries in healthcare, agricultureABLE, WBBA signed an MoU for broad ranging cooperation to support "breakthrough" discoveries in healthcare, agri and clean energy sector.
- Biocon-Mylan partnership has a potential of $33 billion from biosimilar drugsTwo years after announcing a JV with Mylan, Biocon has revealed the potential of its drugs under the biologics deal with Mylan.
- Biotech R&D to get fillip with RS 350cr packageDepartment of biotechnology's latest initiative BIPP could provide a fillip for research, more so in light of industry facing a credit sque...
Load More
